Abstract
Quantitative structure activity relationships were developed for seventeen propenone derivatives reported in the literature that act as dual COX and 5-LOX inhibitors. Predominantly spatial, thermodynamic, topological, and electronic descriptors appear in the models. Docking between these compounds and COX-1, COX-2 and 5-LOX enzymes was also performed and mathematical relationships were developed between the binding energy and activity.
Letters in Organic Chemistry
Title: QSAR and Docking Studies on Propenone Derivatives as Dual COX and 5- LOX Inhibitors
Volume: 5 Issue: 7
Author(s): Ponnurengam M. Sivakumar, Sethu K. Geetha Babu, Vaibhav Sharma and Mukesh Doble
Affiliation:
Keywords: Propenone, NSAID, QSAR, COX -1, COX-2, 5-LOX
Abstract: Quantitative structure activity relationships were developed for seventeen propenone derivatives reported in the literature that act as dual COX and 5-LOX inhibitors. Predominantly spatial, thermodynamic, topological, and electronic descriptors appear in the models. Docking between these compounds and COX-1, COX-2 and 5-LOX enzymes was also performed and mathematical relationships were developed between the binding energy and activity.
Export Options
About this article
Cite this article as:
Sivakumar M. Ponnurengam, Geetha Babu K. Sethu, Sharma Vaibhav and Doble Mukesh, QSAR and Docking Studies on Propenone Derivatives as Dual COX and 5- LOX Inhibitors, Letters in Organic Chemistry 2008; 5 (7) . https://dx.doi.org/10.2174/157017808785982194
DOI https://dx.doi.org/10.2174/157017808785982194 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Objective Biological Measures for the Assessment and Management of Auditory Processing Disorder
Current Pediatric Reviews Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Effect of Cabergoline on Cognitive Impairments in Transgenic <i>Drosophila</i> Model of Parkinson’s Disease
Letters in Drug Design & Discovery RAGE: A Single Receptor for Several Ligands and Different Cellular Responses: The Case of Certain S100 Proteins
Current Molecular Medicine Non-Pharmacologic Treatment Options in Rheumatologic Disease
Current Rheumatology Reviews Design, Synthesis, <i>In Silico</i> and <i>In Vitro</i> Evaluation of Novel Pyrimidine Derivatives as EGFR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Progress and Promise of Nur77-based Therapeutics for Central Nervous System Disorders
Current Neuropharmacology Most Recent Developments and Modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan Derivatives
Mini-Reviews in Medicinal Chemistry Bronsted Acidic Ionic Liquid as an Efficient and Reusable Catalyst for Synthesis of Pyrazoles and β-Enaminones
Current Catalysis Response Conflict as an Environmental Determinant of Gender Differences in Sensitivity to Alcohol Impairment
Current Drug Abuse Reviews Targeting Complement in Rheumatoid Arthritis
Current Rheumatology Reviews A Dual Mechanism Linking NGF/proNGF Imbalance and Early Inflammation to Alzheimer's Disease Neurodegeneration in the AD11 Anti-NGF Mouse Model
CNS & Neurological Disorders - Drug Targets Immunoregulation Through 1,25-Dihydroxyvitamin D 3 and its Analogs
Current Drug Targets - Inflammation & Allergy Pyrimidine Derivatives as Potential Agents Acting on Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Drug Conjugated Nanomedicine as Prodrug Carrier
Nanoscience & Nanotechnology-Asia Role of Connexins and Pannexins in Ischemic Stroke
Current Medicinal Chemistry Synthesis and Anthelmintic Evaluation of Novel Valerolactam- Benzimidazole Hybrids
Letters in Drug Design & Discovery Oxytocin - A Multifunctional Analgesic for Chronic Deep Tissue Pain
Current Pharmaceutical Design Analgesia in PACU: Intravenous Opioids
Current Drug Targets Inpatient Diabetes Management in Non-ICU Settings: Evidence and Strategies
Current Diabetes Reviews